(Q42507192)

1 November 2017

Nonsteroidal anti-inflammatory drugs and the risk of skin cancer: a population-based case-control study (English)

1 reference

1 November 2017

0 references

1 reference

6

Henrik Toft Sørensen

1 reference

1 November 2017

Sigrun Alba Johannesdottir

1

1 reference

1 November 2017

Ellen T Chang

2

1 reference

1 November 2017

Frank Mehnert

3

1 reference

1 November 2017

Morten Schmidt

4

1 reference

1 November 2017

Anne Braae Olesen

5

1 reference

1 November 2017

language of work or name

English

0 references

publication date

29 May 2012

1 reference

1 November 2017

1 reference

1 November 2017

118

1 reference

1 November 2017

19

1 reference

1 November 2017

4768-4776

1 reference

Epidemiology of non-steroidal anti-inflammatory drugs and cancer

1 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Nonsteroidal anti-inflammatory drug use in the prevention and treatment of squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Association between nonsteroidal anti-inflammatory drug use and cutaneous squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

A large cohort study of nonsteroidal anti-inflammatory drug use and melanoma incidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Effect of non-steroidal anti-inflammatory drugs on non-melanoma skin cancer incidence in the SKICAP-AK trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Non-steroidal anti-inflammatory drugs and melanoma risk: large Dutch population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Effect of NSAIDs on the recurrence of nonmelanoma skin cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Analgesic and nonsteroidal anti-inflammatory use in relation to nonmelanoma skin cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Existing data sources for clinical epidemiology: Aarhus University Prescription Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

The Danish Civil Registration System.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Non-melanoma skin cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

What Does the Odds Ratio Estimate in a Case-Control Study?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Pharmacodynamic of cyclooxygenase inhibitors in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Upper gastrointestinal bleeding among users of NSAIDs: a population-based cohort study in Denmark

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Skin cancers associated with autoimmune conditions among elderly adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Rheumatoid arthritis and cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Malignant tumours and psoriasis: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Use of oral glucocorticoids and risk of skin cancer and non-Hodgkin's lymphoma: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Use of photosensitising diuretics and risk of skin cancer: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Cyclooxygenase-2 and skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Factors associated with a continuous regular analgesic use - a population-based study of more than 45,000 Danish women and men 18-45 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Cyclooxygenases in the skin: pharmacological and toxicological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Cancer risk in persons receiving prescriptions for paracetamol: a Danish cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

Long-term use of nonsteroidal anti-inflammatory drugs decreases the risk of cutaneous melanoma: results of a United States case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

inferred from DOI database lookup

7 January 2021

based on heuristic

PUVA and cancer: a large-scale epidemiological study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27406

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCR.27406

1 reference

1 November 2017

1 reference